Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) relating to the proposed acquisition by Mallinckrodt plc (“Mallinckrodt”). Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) shares after opening at $82.00 moved to $85.69 on last trade day and at the end of the day closed at $85.16. Company price to sales ratio in past twelve months was calculated as 6.46 and price to cash ratio as 21.06. Questcor Pharmaceuticals Inc. (NASDAQ:QCOR) showed a positive weekly performance of 23.19%.
MacroGenics, Inc. (NASDAQ:MGNX) saw a big move last session, as the company’s shares fell by nearly 8% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for MGNX as the stock is now down over 39% since March 20. MacroGenics Inc. (NASDAQ:MGNX) shares advanced 4.00% in last trading session and ended the day on $24.17. MGNX return on equity ratio is recorded as 32.00% and its return on assets is -8.40%.
Enzymotec Ltd. (NASDAQ:ENZY) Provides Update on Patent Litigation with Neptune. Enzymotec Ltd (NASDAQ:ENZY) shares moved up 11.06% in last trading session and was closed at $21.69, while trading in range of $19.58 – $21.97. Enzymotec Ltd (NASDAQ:ENZY) year to date (YTD) performance is -19.70%.
Veracyte Inc. (NASDAQ:VCYT) revenue increased $10.4 million, or 89%, from $11.6 million for the year ended December 31, 2012 to $21.9 million for the year ended December 31, 2013,
Veracyte Inc. (NASDAQ:VCYT) weekly performance is -15.99%. On last trading day company shares ended up $14.19. Veracyte Inc. (NASDAQ:VCYT) distance from 50-day simple moving average (SMA50) is -11.38%. Analysts mean target price for the company is $22.50.